Evaluation of the Effect of Gene Duplication by Genome Editing on Drug Resistance in Plasmodium falciparum
出版年份 2022 全文链接
标题
Evaluation of the Effect of Gene Duplication by Genome Editing on Drug Resistance in Plasmodium falciparum
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-07-05
DOI
10.3389/fcimb.2022.915656
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In Vitro Susceptibility of Plasmodium falciparum Isolates from the China–Myanmar Border Area to Piperaquine and Association with Candidate Markers
- (2021) Yu Si et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence of Artemisinin-Resistant Malaria in Africa
- (2021) Betty Balikagala et al. NEW ENGLAND JOURNAL OF MEDICINE
- Highly efficient CRISPR/Cas9 system in Plasmodium falciparum using Cas9-expressing parasites and a linear donor template
- (2021) Tsubasa Nishi et al. Scientific Reports
- AGIA Tag System for Ultrastructural Protein Localization Analysis in Blood-Stage Plasmodium falciparum
- (2021) Masayuki Morita et al. Frontiers in Cellular and Infection Microbiology
- Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
- (2020) Rob W van der Pluijm et al. LANCET
- Refining the transcriptome of the human malaria parasite Plasmodium falciparum using amplification-free RNA-seq
- (2020) Lia Chappell et al. BMC GENOMICS
- Improvement of CRISPR/Cas9 system by transfecting Cas9-expressing Plasmodium berghei with linear donor template
- (2020) Naoaki Shinzawa et al. Communications Biology
- No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border
- (2020) Fang Huang et al. MALARIA JOURNAL
- State of Artemisinin and Partner Drug Susceptibility in Plasmodium falciparum Clinical Isolates from Colombia
- (2020) Lidia Madeline Montenegro et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
- (2019) Rob W van der Pluijm et al. LANCET INFECTIOUS DISEASES
- Dissecting the Gene Expression, Localization, Membrane Topology, and Function of the Plasmodium falciparum STEVOR Protein Family
- (2019) J. Stephan Wichers et al. mBio
- Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research
- (2019) Franziska Mohring et al. eLife
- Chromatin Accessibility-Based Characterization of the Gene Regulatory Network Underlying Plasmodium falciparum Blood-Stage Development
- (2018) Christa Geeke Toenhake et al. Cell Host & Microbe
- Investigating the efficacy of triple artemisinin-based combination therapies (TACTs) for treating Plasmodium falciparum malaria patients using mathematical modelling
- (2018) Saber Dini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
- (2018) Leila S. Ross et al. Nature Communications
- Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine
- (2018) Duangkamon Loesbanluechai et al. International Journal for Parasitology-Drugs and Drug Resistance
- Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity
- (2017) Sonia Agrawal et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study
- (2017) Roberto Amato et al. LANCET INFECTIOUS DISEASES
- A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
- (2017) Benoit Witkowski et al. LANCET INFECTIOUS DISEASES
- A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug Piperaquine
- (2017) Satish K. Dhingra et al. mBio
- Declining Efficacy of Artemisinin Combination Therapy AgainstP. FalciparumMalaria on the Thai–Myanmar Border (2003–2013): The Role of Parasite Genetic Factors
- (2016) Aung Pyae Phyo et al. CLINICAL INFECTIOUS DISEASES
- Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
- (2016) M. Isabel Veiga et al. Nature Communications
- Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations
- (2015) Valentine Duru et al. BMC Medicine
- The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
- (2015) S. Bhatt et al. NATURE
- Four years’ monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border
- (2014) Papichaya Phompradit et al. MALARIA JOURNAL
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- (2014) Elizabeth A. Ashley et al. NEW ENGLAND JOURNAL OF MEDICINE
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- Efficacy of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010
- (2012) R. Leang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- pfmdr1Amplification Is Related to Increased Plasmodium falciparum In Vitro Sensitivity to the Bisquinoline Piperaquine
- (2012) M. I. Veiga et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PfCRT and its role in antimalarial drug resistance
- (2012) Andrea Ecker et al. TRENDS IN PARASITOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now